SCHEMBL6537796

SCHEMBL6537796

Cc1ccc2c(=O)cc[nH]c2c1[N+](=O)[O-]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR8 P51685 1/20 0.53
KMT2A Q03164 2/20 0.52
ALDH1A1 P00352 5/20 0.43
TDP1 Q9NUW8 1/20 0.43
TSHR P16473 3/20 0.42
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
CYP3A4 P08684 1/20 0.39
KDM4E B2RXH2 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GRIN2D O15399 3/20 0.37
GRIN3B O60391 3/20 0.37
GRIN1 Q05586 3/20 0.37
GRIN2A Q12879 3/20 0.37
GRIN2B Q13224 3/20 0.37
GRIN2C Q14957 3/20 0.37
GRIN3A Q8TCU5 3/20 0.37
MCL1 Q07820 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2263267 0.75 ALDH1A1 (0.53) KMT2AALDH1A1TDP1TSHRCYP3A4
SCHEMBL17263930 0.72 TSHR (0.64) KMT2AALDH1A1TDP1TSHRCYP3A4
SCHEMBL6537685 0.72 KMT2A (0.41) CCR8KMT2AALDH1A1TDP1TSHR
SCHEMBL30774416 0.72 CCR8 (1.00) CCR8KMT2AALDH1A1ADORA2AADORA1
SCHEMBL19318056 0.72 CCR8 (1.00) CCR8KMT2AALDH1A1ADORA2AADORA1
SCHEMBL4685683 0.72 ALDH1A1 (0.52) KMT2AALDH1A1TDP1TSHRCYP3A4
SCHEMBL19251836 0.71 TSHR (0.50) KMT2AALDH1A1TDP1TSHRCYP3A4
SCHEMBL6537493 0.70 ALDH1A1 (0.58) CCR8KMT2AALDH1A1TDP1TSHR
SCHEMBL15364938 0.70 ALDH1A1 (0.41) KMT2AALDH1A1TDP1TSHRCYP3A4
SCHEMBL6537634 0.70 GRIN2D (0.49) CCR8KMT2AALDH1A1TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed